Advancing breakthrough solutions in biotechnology

Nue Biotech is a biotechnology company pioneering advancements in regenerative medicine, AI driven diagnostics, and transdermal drug delivery. Established in 2023 and operating across three continents, we develop breakthrough solutions at the intersection of biotech, skin science, and human performance.

Our proprietary research spans multiple disciplines, including AI powered skin diagnostics, cellular repair serums, and microbiome based therapies that enhance skin regeneration and longevity. We are also at the forefront of paramedical tattoo science, developing innovative pigmentation solutions for scar camouflage and inkless stretch mark revision.

Key Management

Bianca Festejo
Chief Executive Officer / Co-Founder
Benjamin Hargreaves
Chief Strategy Officer / Co-Founder
Yoshio Ito, MD
Chief Medical Officer
Francisco Llano, MD
Scientific Advisor

Developing cutting edge solutions that lead the industry

Achievement

Nue Biotech reached a significant milestone with the release of its first patented technology, marking the foundation of its proprietary innovations. This patent solidifies Nue Biotech’s leadership in the industry by setting a new standard for precision skin diagnostics and regenerative formulations, reinforcing our commitment to groundbreaking advancements in biotech and transdermal science.

Progression

Nue Biotech is now advancing toward AI driven skin analysis and vitamin based skin technology. By integrating artificial intelligence with biometric data, we aim to enhance personalized skincare solutions and optimize skin health at a molecular level. These next generation innovations will redefine how skin is analyzed, treated, and nourished, setting a new benchmark in AI powered dermatological science.